The latest updates in hospital medicine
A tour of high-yield 2022-23 non-COVID literature.
“Austin City Limits” is one the nation’s most popular annual music festivals. But hospitalists will want to take a listen to “Austin City Lit.” That’s “Lit” as in “literature.” Two speakers will walk through eight of the top research studies from the past year on topics ranging from acetazolamide to SGLT2 inhibitors. These studies could have you considering whether to change your practice to “Save a Life Tonight,” or just “Let it Be.”
Heather E. Nye, MD, PHD, SFHM, associate chief of medicine at San Francisco VA Healthcare System and professor at UCSF, and Rahul B. Ganatra, MD, MPH, director of CME, VA Boston Healthcare System, said Wednesday’s session “Updates in Hospital Medicine,” 2:10-3:10 p.m., will be a lively and fun review of the most important practice-changing literature from the past year in hospital medicine.
“Hospitalists play a critical role not only during acute illness, but in putting into motion care plans that impact outcomes well beyond discharge,” Dr. Nye said. Drs. Nye and Ganatra will review and summarize the evidence base that hospitalists can use to start patients on their journeys to better health.
Eight important studies will be explored. Here are some questions that will be addressed:
- Is rapid up-titration of GDMT for heart failure after hospitalization for acute heart failure safe and effective?
- Among patients hospitalized with acute heart failure, does the addition of acetazolamide improve decongestion over loop diuretics alone?
- Should SGLT2 inhibitors be started during hospitalization for acute heart failure?
- What is the best fluid resuscitation strategy in patients with acute pancreatitis?
- What percentage of Americans know what a hospitalist does?
"Keeping up with the medical literature can be challenging for busy clinicians,” said Dr. Ganatra. “Our goal for this session is to deliver an engaging and practical summary of practice-changing studies from the past year."
Visit SHM Meeting News Central for more coverage.